BRIEF-ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner And Global Allergy Leader Alk-Abello A/S

Reuters
02 May
BRIEF-ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner And Global Allergy Leader Alk-Abello A/S

May 2 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:

  • ARS PHARMACEUTICALS ANNOUNCES CO-PROMOTION AGREEMENT WITH PARTNER AND GLOBAL ALLERGY LEADER ALK-ABELLÓ A/S TO EXPAND REACH OF NEFFY® (EPINEPHRINE NASAL SPRAY) TO ADDITIONAL U.S. PEDIATRICIANS

  • ARS PHARMACEUTICALS INC - PHARMA RECEIVED $145 MILLION UPFRONT FROM ALK

Source text: ID:nGNX9l0S2V

Further company coverage: SPRY.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10